Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.52
-0.5900-18.97%
Post-market: 2.520.00000.00%19:58 EDT
Volume:1.24M
Turnover:3.21M
Market Cap:6.01M
PE:-0.01
High:2.74
Open:2.69
Low:2.41
Close:3.11
Loading ...
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 07, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 06, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 15, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 15, 2025

Correspondence

Form CORRESP - Correspondence
Dec 27, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 11, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Aug 28, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 28, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 15, 2024

Major Issues Report

Form 8-K - Current report